Fibrinogen Hershey IV: A novel dysfibrinogen with a γV411I mutation in the integrin αIIbβ3 binding site

Thrombosis and Haemostasis

Volumn 99, Issue 6, 2008, Pages 1008-1012

  Flood, Veronica H ^a,b   Al Mondhiry, Hamid A ^c   Rein, Chantelle M ^a   Alexander, Kristine S ^a   Lovely, Rehana S ^a   Shackleton, Kelley M ^a   David, Larry L ^a   Farrell, David H ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Fibrinogen fibrin; GP IIb IIIa; Inherited coagulation disorders; Integrins; Platelet glycoproteins

Indexed keywords

ALPHA INTEGRIN; ALPHA2B BETA3 INTEGRIN; FIBRIN; FIBRINOGEN; FIBRINOGEN HERSHEY IV; FIBRINOGEN RECEPTOR; INTEGRIN;

ADULT; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BINDING SITE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; THROMBOCYTE AGGREGATION;

BINDING SITES; BLOOD PLATELETS; DNA MUTATIONAL ANALYSIS; FEMALE; FIBRINOGENS, ABNORMAL; HETEROZYGOTE; HUMANS; MIDDLE AGED; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POINT MUTATION; PROTEIN BINDING;

EID: 44949196653     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-06-0427     Document Type: Article

References (34)

1. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005; 70: 247-299.
2. Mosesson MW. Fibrinogen γ chain functions. J Thromb Haemost 2003; 1: 231-238.
3. Farrell DH. Pathophysiologic roles of the fibrinogen γ chain. Curr Opin Hematol 2004; 11: 151-155.
4. Chen R, Doolittle RF. γ-γ cross-linking sites in human and bovine fibrin. Biochemistry 1971; 10: 4487-91.
5. Lorand L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann NY Acad Sci 2001; 936: 291-311.
6. Kloczewiak M, Timmons S, Lukas TJ, et al. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the γ chain. Biochemistry 1984; 23: 1767-1774.
7. Kloczewiak M, Timmons S, Bednarek MA, et al. Platelet receptor recognition domain on the γ chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 1989; 28: 2915-2919.
8. Cheresh DA, Berliner SA, Vicente V, et al. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-953.
9. Farrell DH, Thiagarajan P, Chung DW, et al. Role of fibrinogen α and γ chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-10732.
10. Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994; 269: 226-231.
11. 3. J Clin Invest 2005; 115: 3363-3369.
12. Chung DW, Davie EW. γ and γ′ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-4236.
13. Fornace AJ, Jr, Cummings DE, Comeau CM, et al. Structure of the human γ-fibrinogen gene. Alternate mRNA splicing near the 3′ end of the gene produces γA and γB forms of γ-fibrinogen. J Biol Chem 1984; 259: 12826-12830.
14. Kirschbaum NE, Mosesson MW, Amrani DL. Characterization of the γ chain platelet binding site on fibrinogen fragment D. Blood 1992; 79: 2643-2648.
15. Lawrence SO, Wright TW, Francis CW, et al. Purification and functional characterization of homodimeric γB-γB fibrinogen from rat plasma. Blood 1993; 82: 2406-2413.
16. Neerman-Arbez M. Molecular basis of fibrinogen deficiency. Pathophysiol Haemost Thromb 2006; 35: 187-198.
17. Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol 2001; 114: 249-257.
18. Ebert RF. Dysfibrinogenemia: an overview of the field. Thromb Haemost 1991; 65: 1317.
19. Hanss M, Biot F. A database for human fibrinogen variants. Ann NY Acad Sci 2001; 936: 89-90.
20. Flood VH, Al-Mondhiry HA, Farrell DH. The fibrinogen Aα R16C mutation results in fibrinolytic resistance. Br J Haematol 2006; 134: 220-226.
21. Kazal LA, Amsel S, Miller OP, et al. The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 1963; 113: 989-994.
22. Lovely RS, Falls LA, Al-Mondhiry HA, et al. Association of γA/γ′ fibrinogen levels and coronary artery disease. Thromb Haemost 2002; 88: 26-31.
23. 3 complex and with fibrinogen Aα-chain. Thromb Res 1997; 85: 115-126.
24. Meh DA, Siebenlist KR, Brennan SO, et al. The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thromb Haemost 2001; 85: 470-474.
25. Liu Q, Matsueda G, Brown E, et al. The AGDV residues on the γ chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation. Biochim Biophys Acta 1997; 1343: 316-326.
26. 3. EMBO J 1996; 15: 5760-5771.
27. Denninger MH, Jandrot-Perrus M, Elion J, et al. ADP-induced platelet aggregation depends on the conformation or availability of the terminal γ chain sequence of fibrinogen. Study of the reactivity of fibrinogen Paris 1. Blood 1987; 70: 558-563.
28. Cote HC, Lord ST, Pratt KP. γ chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the ? chain of human fibrinogen. Blood 1998; 92: 2195-212.
29. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73: 151-161.
30. Linenberger ML, Kindelan J, Bennett RL, et al. Fibrinogen Bellingham: a γ chain R275C substitution and a β-promoter polymorphism in a thrombotic member of an asymptomatic family. Am J Hematol 2000; 64: 242-250.
31. Siebenlist KR, Mosesson MW, Meh DA, et al. Coexisting dysfibrinogenemia (gR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids). Blood Coagul Fibrinolysis 2000; 11: 293-304.
32. Mosesson MW, Siebenlist KR, DiOrio JP, et al. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (γ275 Arg→Cys). J Clin Invest 1995; 96: 1053-1058.
33. Ishikawa S, Hirota-Kawadobora M, Tozuka M, et al. Recombinant fibrinogen, γ275Arg→Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions. J Thromb Haemost 2004; 2: 468-475.
34. Schmelzer CH, Ebert RF, Bell WR. Fibrinogen Baltimore IV: congenital dysfibrinogenemia with a γ275 (Arg→Cys) substitution. Thromb Res 1989; 56: 307-316.